News
Virios Therapeutics Announces Publication Of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID
26 Mar 24
Biotech, News, General
12 Health Care Stocks Moving In Monday's Pre-Market Session
25 Mar 24
Movers
12 Health Care Stocks Moving In Friday's Intraday Session
22 Mar 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
21 Mar 24
Movers
Virios Therapeutics Q4 2023 GAAP EPS $(0.06) Beats $(0.09) Estimate
29 Feb 24
Earnings, Earnings Beats, News
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress And Key Upcoming Milestones; All Of Virios' Employees Have Agreed To A 10% Salary Compensation Reduction In Exchange For Future Vesting Stock Options
28 Feb 24
News, Management
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Feb 24
Movers
Press releases
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
2 May 24
Health Care, Press Releases
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
26 Mar 24
Health Care, Press Releases, General
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
29 Feb 24
Earnings, Press Releases
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
28 Feb 24
Press Releases